Access to Pharmaceuticals > Case Studies in Global Health

Case Studies in Global Health

A large part of ATP consortium research consists of analysis of specific examples (case studies) of initiatives and mechanisms to promote global health through affordable access to pharmaceutical and vaccine technologies. Some of the cases we are analyzing are listed below:

Efavirenz generic version by FarManguinhos, Brazil

Efavirenz generic version by FarManguinhos, Brazil

In 2007, the most used drug in antiretroviral (ARV) treatment in Brazil was “efavirenz”, provided by the company Merck under the brand name Stocrin.  The year’s price for the medicine was US $ 580 per patient. Due to Brazil’s universal access to treatment program, about 75,000 people were eligible to receive efavirenz.  In international comparison, the cost for the drug in Thailand was approximately US $ 245 per patient, and the eligible number of patients was about 17,000 people. Moreover, the prices for the supply of efavirenz by WHO prequalified laboratories, proposed to Brazil by UNICEF, ranged around US $ 163. Read more…